Tumour tissue selectivity in the uptake and retention of SN 28049, a new topoisomerase II-directed anticancer agent.
about
Selective cellular uptake and retention of SN 28049, a new DNA-binding topoisomerase II-directed antitumor agent.Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects.Classical and Targeted Anticancer Drugs: An Appraisal of Mechanisms of Multidrug Resistance.
P2860
Tumour tissue selectivity in the uptake and retention of SN 28049, a new topoisomerase II-directed anticancer agent.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tumour tissue selectivity in t ...... II-directed anticancer agent.
@en
Tumour tissue selectivity in t ...... II-directed anticancer agent.
@nl
type
label
Tumour tissue selectivity in t ...... II-directed anticancer agent.
@en
Tumour tissue selectivity in t ...... II-directed anticancer agent.
@nl
prefLabel
Tumour tissue selectivity in t ...... II-directed anticancer agent.
@en
Tumour tissue selectivity in t ...... II-directed anticancer agent.
@nl
P2093
P2860
P1476
Tumour tissue selectivity in t ...... II-directed anticancer agent.
@en
P2093
Bruce C Baguley
Emma Richardson
Graeme J Finlay
Pradeep B Lukka
Wayne R Joseph
Ying Yi Chen
P2860
P2888
P304
P356
10.1007/S00280-013-2280-0
P577
2013-09-14T00:00:00Z